Large proteoglycan complexes and disturbed collagen architecture in the corneal extracellular matrix of mucopolysaccharidosis type VII (Sly syndrome).
暂无分享,去创建一个
A. Quantock | M. Tesařová | J. Zeman | R. Young | K. Jirsova | K. Meek | C. Knupp | M. Elleder | P. Lišková | C. Pinali | M. Palos | E. Hrdličková | B. Palka
[1] K. Nishida,et al. Electron tomography reveals multiple self-association of chondroitin sulphate/dermatan sulphate proteoglycans in Chst5-null mouse corneas. , 2011, Journal of structural biology.
[2] K. Ponder,et al. Gene therapy for ocular problems in mucopolysaccharidosis: an experimental and promising approach with benefits in animal models – a review , 2010 .
[3] J. Jester,et al. Genetic basis of corneal diseases and the role of keratocytes in corneal transparency – a review , 2010 .
[4] H. Dua,et al. Application of (lamellar) keratoplasty and limbal stem cell transplantation for corneal clouding in the mucopolysaccharidoses – a review , 2010 .
[5] A. Tormene,et al. Ocular manifestations in the mucopolysaccharidoses – a review , 2010 .
[6] A. Quantock,et al. Elucidation of Collagen-Proteoglycan Interactions in the Mouse Corneal Stroma by Electron Tomography , 2010 .
[7] A. Quantock,et al. Structural interactions between collagen and proteoglycans are elucidated by three-dimensional electron tomography of bovine cornea. , 2010, Structure.
[8] R. Iozzo,et al. Collagen fibril organization in the pregnant endometrium of decorin‐deficient mice , 2010, Journal of anatomy.
[9] W. Sly,et al. Human Mutation MUTATION UPDATE Mutations and Polymorphisms in GUSB Gene in Mucopolysaccharidosis VII (Sly Syndrome) , 2009 .
[10] A. Quantock,et al. The architecture of the cornea and structural basis of its transparency. , 2009, Advances in protein chemistry and structural biology.
[11] L. Schaefer,et al. Proteoglycans: from structural compounds to signaling molecules , 2009, Cell and Tissue Research.
[12] J. Biswas,et al. Ocular manifestation of storage diseases , 2008, Current opinion in ophthalmology.
[13] W. Sly,et al. Infused Fc-tagged β-glucuronidase crosses the placenta and produces clearance of storage in utero in mucopolysaccharidosis VII mice , 2008, Proceedings of the National Academy of Sciences.
[14] Satoshi Kawasaki,et al. Small-angle fibre diffraction studies of corneal matrix structure: a depth-profiled investigation of the human eye-bank cornea , 2007 .
[15] Philip Lewis,et al. Matrix morphogenesis in cornea is mediated by the modification of keratan sulfate by GlcNAc 6-O-sulfotransferase , 2006, Proceedings of the National Academy of Sciences.
[16] I. Date,et al. Encapsulation cell therapy for mucopolysaccharidosis type VII using genetically engineered immortalized human amniotic epithelial cells. , 2006, The Tohoku journal of experimental medicine.
[17] S. Biswas,et al. Mucopolysaccharidoses and the eye. , 2006, Survey of ophthalmology.
[18] 刘金明,et al. IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW,Thompson RW,et al//Proc Natl Acad Sci U S A , 2005 .
[19] Ashutosh Kumar Singh,et al. Morquio syndrome: electron microscopic findings , 2005, British Journal of Ophthalmology.
[20] K. Fukuda,et al. Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts. , 2005, Investigative ophthalmology & visual science.
[21] M. Iwamoto,et al. Ocular histopathology and ultrastructure of Morquio syndrome (systemic mucopolysaccharidosis IV A) , 1990, Graefe's Archive for Clinical and Experimental Ophthalmology.
[22] Y. Cheng,et al. Mucopolysaccharidosis type VII as a cause of recurrent non-immune hydrops fetalis , 2003, Journal of perinatal medicine.
[23] Sanford M. Simon,et al. Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells , 2002, The Journal of cell biology.
[24] Marian F Young,et al. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. , 2002, Glycobiology.
[25] S. Akhtar,et al. Clinical and morphological features including expression of βig-h3 and keratan sulphate proteoglycans in Maroteaux-Lamy syndrome type B and in normal cornea , 2002, The British journal of ophthalmology.
[26] P. Roughley,et al. Catabolism of Proteoglycans , 2000 .
[27] P. Neame,et al. Small Leucine-Rich Proteoglycans , 2000 .
[28] B. Glasgow,et al. Corneal transplantation in a patient with mucopolysaccharidosis type VII (Sly disease) , 2000, Ophthalmic genetics.
[29] W. Sly,et al. Enzyme Replacement in Murine Mucopolysaccharidosis Type VII: Neuronal and Glial Response to β-Glucuronidase Requires Early Initiation of Enzyme Replacement Therapy , 1999, Pediatric Research.
[30] J. Alroy,et al. Altered corneal stromal matrix organization is associated with mucopolysaccharidosis I, III and VI. , 1999, Experimental eye research.
[31] F. Reinholt,et al. Fibromodulin-null Mice Have Abnormal Collagen Fibrils, Tissue Organization, and Altered Lumican Deposition in Tendon* , 1999, The Journal of Biological Chemistry.
[32] Terry Magnuson,et al. Lumican Regulates Collagen Fibril Assembly: Skin Fragility and Corneal Opacity in the Absence of Lumican , 1998, The Journal of cell biology.
[33] K. Meek,et al. X‐Ray Diffraction and Transmission Electron Microscopy of Morquio Syndrome Type A Cornea: A Structural Analysis , 1997, Cornea.
[34] R. Vervoort,et al. Molecular analysis of the ß-glucuronidase gene: novel mutations in mucopolysaccharidosis type VII and heterogeneity of the polyadenylation region , 1997, Human Genetics.
[35] Renato V. Iozzo,et al. Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility , 1997, Journal of Cell Biology.
[36] A. Vellodi,et al. Ultrastructural study of the cornea in a bone marrow-transplanted Hurler syndrome patient. , 1996, Experimental eye research.
[37] W. Sly,et al. Molecular analysis of patients with beta-glucuronidase deficiency presenting as hydrops fetalis or as early mucopolysaccharidosis VII. , 1996, American Journal of Human Genetics.
[38] G. Aguirre,et al. Corneal Endothelium in Mucopolysaccharide Storage Disorders: Morphologic Studies in Animal Models , 1996, Cornea.
[39] A. Quantock,et al. Scheie's syndrome: the architecture of corneal collagen and distribution of corneal proteoglycans. , 1993, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[40] W. Sly,et al. Photoreceptor degeneration and altered distribution of interphotoreceptor matrix proteoglycans in the mucopolysaccharidosis VII mouse. , 1993, Experimental eye research.
[41] M. Sands,et al. Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer , 1992, Nature.
[42] W. Nyhan,et al. A new quantitative assay for glycosaminoglycans. , 1992, Clinica chimica acta; international journal of clinical chemistry.
[43] W. Sly,et al. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. , 1991, Blood.
[44] E. Traboulsi,et al. Optic nerve head swelling and optic atrophy in the systemic mucopolysaccharidoses. , 1990, Ophthalmology.
[45] H. Kresse,et al. Degradation of endocytosed dermatan sulfate proteoglycan in human fibroblasts. , 1988, The Journal of biological chemistry.
[46] R. Gitzelmann,et al. Unusually mild course of beta-glucuronidase deficiency in two brothers (mucopolysaccharidosis VII). , 1978, Helvetica paediatrica acta.
[47] Lorincz Ae. The mucopolysaccharidoses: advances in understanding and treatment. , 1978, Pediatric annals.
[48] A. E. Lorincz. The mucopolysaccharidoses: advances in understanding and treatment. , 1978, Pediatric annals.
[49] W. Sly,et al. Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. , 1973, The Journal of pediatrics.
[50] R. Giugliani,et al. The mucopolysaccharidoses. , 1976, Journal of medical genetics.